FBXW7 and ovarian cancer: Xu and the colleague revealed that F-box and WD repeat domain-containing 7 (FBW7) suppressed ovarian cancer progression through targeting the m6A binding protein YTH domain family 2 (YTHDF2) (Xu et al., 2021).